baber/WOPTO huggingface dataset:
Patent IL-60427-A0 (IL)
Title: Decontamination of wet-processed phosphoric acid
IPC: C01B25/46
Filed: 1980-06-27
Abstract: The invention relates to the decontamination of wet-processed phosphoric acid with the use of organic solvents in a plurality of extraction zones, of which each is comprised of a mixing zone and a separating zone, the solvent being immiscible or partially miscible with water. Resulting organic phase and the aqueous phase are contacted countercurrently with respect to one another, the organic solvent phase being dispersed in the aqueous phase. To this end, the invention provides for the aqueous phase to be admitted to the mixing zone at the onset of the extraction, and for organic phase and aqueous phase to be continuously admitted in a volume ratio of at least 2.5:1 to the respective extracting zones in an overall quantity sufficient to provide, in the mixing zones of the extraction zones, a volume ratio of organic phase to aqueous phase of at most 1:1, which is maintained therein.
Patent IL-65421-A0 (IL)
Title: Device for the production of sweet water from seawater
IPC: C02F1/18
Filed: 1982-04-05
Abstract: The invention concerns a fresh-water producing apparatus to be immersed in a marine medium and of the type comprising at least one reverse-osmosis selective semi-permeable membrane. This apparatus comprises three stages: a fresh-water stage consisting of collecting means for the produced chamber provided with a semi-permeable membrane placed between this chamber and the fresh-water collecting means; and, a third stage comprising a mobile piston and an hermetic chamber having a gaseous atmosphere. The piston is designed to enter in variable depth the high-pressure chamber by one side having an effective area s and comprising an opposite side with an effective area S exceeding the area s and arranged to be at the pressure of the marine medium.
Patent IL-83745-A0 (IL)
Title: Ceramic articles with a polymer component and methods of making same
IPC: C04B35/00
Filed: 1987-09-02
Abstract: A method of producing self-supporting ceramic bodies (12) having a polymer component, which includes first providing a self-supporting ceramic body (12) comprising (i) a polycrystalline oxidation reaction product formed upon oxidation of a molten parent metal with an oxidant, and (ii) interconnected porosity (13) at least partially accessible from one or more surfaces of said ceramic body. The polymer is disposed or formed within the interconnected porosity (13). The polymer is situated so as to alter, modify or contribute to the properties of the ceramic body (12) originally formed.
Patent AU-PQ381499-A0 (AU)
Title: Enhanced direct digitising array arrangement
IPC: H03M1/08
Filed: 1999-11-02
Abstract: The invention comprises an array of ADCs, associated either with spatially separated signal input devices such as for example antennae, or with a single signal input device and a plurality of filters having a variable phase delay, which provide a digital output which is processed to remove spurious signals introduced by the ADCs thereby providing a linearised output. In one embodiment an array of N antennae with respective band pass filters and ADCs (10) feeds received signals into a frequency channelisation device (12) which divides each of the N input streams into M lower bandwidth streams for distribution. In a first path, an FFT (14) is used to detect signals of interest, to determine where intermodulation products are likely to exist and to provide coarse data for the spatial processing used in the signal separation sub-systems. The second path (16) includes the detection of co-channels signals using algorithms such as Eigenvalue Decomposition. If these co-channel signals are spatially distinct they are separated using spatial processing algorithms such as, MUSIC and generalized side lobe cancellation and if they are spatially indistinct they are separated by Higher Order Statistical (HOS) processing algorithms such as Joint Approximate Diagonalization of Eigen-matrices (JADE). Signal classification techniques are then used to identify spurious signals, which are then removed. These processes linearise the output of the ADCs. The final stage in the process is the demodulation and decoding (18) of the signal of interest. Controlling the total system will be a control and recording system (20), that is typically accessed by a pool of users (22) each of whom are interested in a particular SOI at any one time. Clearly, the embodiment is related to a RF receiver arrangement, but its primary architecture is that of an array of ADCs, separated either spatially or with filters having a variable phase delay which in such a configuration can provide a higher dynamic range Analogue to Digital conversion than previously achievable.
Patent FI-20002127-A0 (FI)
Inventor: PETTERSSON KIM
IPC: G01N33/531
Filed: 2000-09-27
Abstract: This invention concerns an antibody which binds with high affinity to human single-chain intact, i.e. not internally cleaved, mature and/or zymogen forms of prostate specific antigen (SCINT PSA). The antibody does not bind to a nicked PSA (PSA-N), wherein said PSA-N has been formed by internal peptide bond cleavage(s) of SCINT PSA resulting in two-chain or multi-chain PSA. This invention further concerns an immunoassay and a method for differentiating patients with cancer of the prostate (PCa) from patients with benign prostatic hyperplasia (BPH) and/or healthy male subjects without PCa, patients with aggressive PCa from patients with indolent PCa and/or patients with clinically localized and/or organ confined PCa from patients with extraprostatic extension of PCa and/or PCa with metastatic spread to lymph nodes or bone marrow using said antibody.
Patent FI-20050382-A0 (FI)
Inventor: SÄMPI JOUKO
IPC: D06F58/10
Filed: 2005-04-14
Abstract: A heat pump operated drying chamber, which comprises a first chamber part (1) for goods to be dried, a second chamber part (2) for the heat pump equipment and a rotatable drum (8) placed in the first chamber part (1) and in an easy way installed into and removed from chamber part (1), as let down on rolls (13),(14) installed in the chamber part, and drying air is conducted into drying drum (8) through free opening (17) arranged in the drum end and out from drum through holes in the other drum end.
Patent IL-101805-A0 (IL)
Title: Process for producing a heterocyclic tertiary amine
IPC: C07B61/00
Filed: 1992-05-06
Abstract: A process for producing a heterocyclic tertiary amine of the formula (III): <CHEM> wherein A is a nitrogen atom or C-R<5>, B is a nitrogen atom or C-R<6>, ---- is a single bond or a double bond, and each of R<1>, R<2>, R<3>, R<4>, R<5> and R<6> which may be the same or different, is a hydrogen atom , an acyl group, a halogen atom, a cyano group, etc., provided that two of R<1>, R<2>, R<3> and R<4> may together form a 3-membered, 4-membered, 5-membered or 6-membered aliphatic ring, a heterocyclic ring or aromatic ring, and R<7> is a C1-6 alkyl group which may be substituted, etc., which process comprises reacting a heterocyclic secondary amine of the formula (I): <CHEM> wherein A, B, ----, R<1>, R<2>, R<3> and R<4> are as defined above, with an alkylating agent of the formula (II):    R<7>-X   (II> wherein R<7> is as defined above, and X is a hydroxyl group, a halogen atom, a OSO3R<7> group, a OSO2R<7> group, a OCO2R<7> group, a OCOR<7> group, a OP(O)(OR<7>) group, a OP(O)O(R<7>)2 group or an amino group, in the presence of a catalyst of Group VIII of the Periodic Table.
Patent IL-104304-A0 (IL)
Title: Transgenic animal models for alzheimer's disease
IPC: C12N15/85
Filed: 1993-01-04
Abstract: The construction of transgenic animal models for testing potential treatments for Alzheimer's disease are described. The models are characterized by a greater similarity to the conditions existing in naturally occurring Alzheimer's disease, based on expression of all three forms of the  beta -amyloid precursor protein (APP), APP695, APP751, and APP770), as well as various point mutations based on naturally occurring mutations, such as the London and Indiana familial Alzheimer's disease (FAD) mutations at amino acid 717, and predicted mutations in the APP gene. The APP gene constructs are prepared using the naturally occurring promoter, as well as inducible promoters such as the mouse metallothionine promoter, which can be regulated by addition of heavy metals such as zinc to the animal's water or diet, and promoters such as the rat neuron specific enolase promoter, human  beta  actin gene promoter, human platelet derived growth factor B (PDGF-B) chain gene promoter, rat sodium channel gene promoter, mouse myelin basic protein gene promoter, human copper-zinc superoxide dismutase gene promoter, and mammalian POU-domain regulatory gene promoter. The constructs are introduced into animal embryos using standard techniques such as microinjection. Animal cells can be isolated from the transgenic animals or prepared using the same constructs with standard techniques such as lipofection or electroporation. The transgenic animals, or animal cells, are used to screen for compounds altering the pathological course of Alzheimer's Disease as measured by their effect on the amount and histopathology of APP and  beta -amyloid peptide in the animals, as well as by behavioral alterations.
Patent IL-105424-A0 (IL)
Title: Heterocyclic compounds
IPC: A61P9/12
Filed: 1993-04-16
Abstract: The present invention relates to certain novel heterocyclic compounds which are 1-pyridylacetamide compounds of formula (I), set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic compounds, processes for preparing the heterocyclic compounds, pharmaceutical compositions containing such heterocyclic compounds and methods for their use.
Patent IL-107387-A0 (IL)
Title: Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
IPC: A61K39/295
Filed: 1993-10-25
Abstract: A combined pediatric vaccine composition featuring, in a single immunizing dose, a mixture of diphtheria, tetanus and pertussis antigens and a conjugate of fragments of the capsular polysaccharide antigen of Haemophilus influenzae type b and CRM197 protein in a pharmaceutically acceptable aqueous vehicle is provided. The combined vaccine composition exhibits an enhanced antibody response by infants to each of the four vaccine components.
Patent IL-108139-A0 (IL)
Title: Pharmaceutical compositions containing folic acid analogues and protecting agents
IPC: A61K45/00
Filed: 1993-12-22
Abstract: The use of a protecting agent, for example a folate derivative such as folic acid or leucovorin, in combination with a non-competitive folic acid analogue, for example benzoquinazoline derivatives, for use in reducing the side effects associated with the administration of such non-competitive folic acid analogues, and pharmaceutical formulations comprising such combinations are disclosed.
Patent IL-112931-A0 (IL)
Title: Method and apparatus for making an ophthalmic lens
IPC: G02C7/02
Filed: 1995-03-08
Abstract: A method and apparatus for making an ophthalmic lens pumps monomer into one end of a gas permeable tube along its interior length while a chamber surrounding the gas permeable tube is maintained at a subatmospheric pressure by means of a vacuum pump. Preferably, the gas permeable tube is made of silicon rubber. Static mixers introduce mixing into the flow of the monomer within the tube in order to expose the bulk of the monomer to the gas permeable walls of the tube. Under such conditions in the gas permeable tube, the majority of the dissolved gasses are removed from the monomer and continue to be drawn out of the chamber by the pump connected to the chamber. The degassed monomer is then transferred into a mold where it is polymerized into an ophthalmic lens.
Patent IL-132256-A0 (IL)
Title: Ferrule with relief to reduce galling
IPC: F16L19/00
Filed: 1998-04-14
Abstract: A recess (40) is located generally midway between the opposite ends of a ferrule (22' and this results in the inner surface of the rear ferrule being reduced to two relatively narrow contact areas (42,44). The forces are conducted from the front ferrule through the rear ferrule to a nut surface or flange (32' which tend to be directed more radially outward. The outer radial wall (50) of the rear ferrule includes a conical section that increases in radial dimension as it extends from the forward nose portion, that is received in the rear chamfer region (52) of the front ferrule, to the rear flange (26'). Preferably, the outer wall has a uniform angle or taper as it extends between the reduced dimension nose region received in the camming mouth of the front ferrule and the enlarged diameter rear flange. This provides controlled deformation of the rear ferrule so that the region is plastically deformed radially inward along surface (44) into gripping, scaled engagement with the outer wall of the tube. The rear ferrule in which the recess (40) is defined by two different angles (an obtuse triangle). The smaller first angle is defined with the inner surface which increases as it extends rearwardly from the surface toward the rear flange. The larger second angle increases as it extends forwardly from the surface (42) toward the nose region. These angles thus intersect at an axial position that is located beneath the intersection of the outer wall with the rear flange.
Patent IL-147688-A0 (IL)
Title: Synergistic combination
IPC: A61P43/00
Filed: 2000-08-11
Abstract: The invention relates to the combined administration of PDE inhibitors and ² 2  adrenoceptor agonists for the treatment of respiratory tract disorders.
Patent IL-148153-A0 (IL)
Title: Vaccines from infectious agents
IPC: A61K/
Filed: 2000-08-18
Abstract: The present invention relates to a method for producing and isolating specific immunogenic endogenous heat shock proteins induced by the treatment of extra-cellular pathogens with stress inducing stimuli and vaccines prepared from such proteins.
Patent IL-150284-A0 (IL)
Title: Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators
IPC: G01N33/542
Filed: 2000-12-21
Abstract: The invention provides a homogeneous assay for nucleic acid hybridization. The fluorescent intensity of a hybridization medium containing a probe, a target and an intercalating agent is a function of the hybridization efficiency of the probe with respect to the target. The assay can detect specific hybridization between single-stranded probes and non-denatured double-stranded targets to form triplexes, thus obviating the need to denature the targets. The assay can also detect duplex hybridization complexes. The assay can be used to identify accessible regions in folded nucleotide sequences, to determine the number of mismatched pairs in a hybridization complex, and to map genomes.
Patent IL-159870-A0 (IL)
Title: Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids designed to increase the intramyocellular lipid level
IPC: A23L33/00
Filed: 2002-07-10
Abstract: The present invention pertains to nutritional compositions containing specific blends of dietary lipids adapted to specifically influence the level of intramyocellular lipids in muscle tissue towards either higher concentrations or lower concentrations. <IMAGE>
Patent IL-165073-A0 (IL)
Title: System and method for the detection and compensation of radio signal time of arrival errors
IPC: G01S1/00
Filed: 2004-11-07
Abstract: A system and method to reduce-the effects of TOA errors. A mobile unit, generates a correlation pulse when a signal transmitted from a base station is detected. The transmitted signal may be reflected or defracted such that multipath signals arrive at the mobile unit, leading to distortion in the generated correlation pulse and errors in accurate TOA measurements. The system models the response function and calculates the width of the pulse using the modeling function with a dynamically adjustable factor to indicate at what point down from the peak the pulse width will be calculated. Based on calculation of pulse width, a type of multipath signal may be determined and an appropriate correction factor applied to the measured TOA to provide a more accurate TOA determination. The system may apply correction factors to TOA signals from base stations in a mobile telephone unit or from signals received from GPS satellites.
Patent IL-165080-A0 (IL)
Title: Method and reagents for n-alkylating ureides
IPC: A61K31/515
Filed: 2004-11-07
Abstract: The present invention is directed to alkoxyalkylated ureides selected from N-methoxymethyl ethosuximide, N-methoxymethyl glutethimide, N-methoxymethyl-5,5-diphenylbarbituric and the therapeutical uses thereof.
Patent RO-134100-A0 (RO)
Title: Ecological installation for separating metals from poor ores
Inventor: ŢUŢURAŞ - HAIDUC VASILE - COSMIN
IPC: B03C7/02
Filed: 2019-11-27
Abstract: The invention relates to an ecological installation for separating metals from poor ores. According to the invention, the installation consists of six cylindrical vertical enclosures (1), hexagonally placed and connected to an electromotor (2) with high power and speed variator, each enclosure (1) being provided at the top with a chamber (9) for storing the mixed ore powder, with an electrically-operated valve (3) located in the middle and with some electrically insulated pipes (4), each pipe (4) being provided with a stainless steel sieve (5) and supplied with direct current by a Van der Graff generator (6) fixed on a support (7), which separates the metal particles, which are then concentrated in lower storage containers (8).
Patent MC-1842-A1 (MC)
Inventor: LUIGI FRATESCHI
IPC: B31B50/02
Filed: 1987-09-10
Abstract: Insulated bag of the type with a double wall, consisting of a pair of polyethylene sheets (1, 2) held apart by a material (3) ensuring the presence of a layer of air, characterised in that the said material is of the type formed by a thin and flexible film which carries, on one face, bubbles or blisters of constant thickness and which are uniformly distributed over this face. <IMAGE>
Patent MA-27188-A1 (MA)
Title: Aminoacides a affinite pour la proteine alpha-2-delta
Inventor: BARTA NANCY SUE
IPC: A61P21/00
Filed: 2004-09-24
Abstract: DEPOSANT Société dite : WARNER-LAMBERT COMPANY LLC REVENDICATION DE PRIORITES US	28 Mars 2002	60/368,413 Voir en annexe le titre de l'invention et le texte de l'abrégé Aminoacides à affinité pour la protéine alpha-2-delta La présente invention concerne certains (bêta)-aminoacides qui se lient à la sous-unité alpha-2-delta ((alpha)2(delta)) d'un canal calcium. Ces composés et leurs sels pharmaceutiquement acceptables sont utiles dans le traitement de divers troubles psychiatriques, de la douleur et d'autres affections.
Patent UY-26917-A1 (UY)
Title: Procedimiento para la producción de plantas transgénicas
Inventor: CONKLING MARK A
IPC: C12N1/19
Filed: 2001-08-30
Abstract: La invención describe ácido nucleico aislado que es un elemento responsivo de un producto de gen Nic, y su uso en métodos para producir plantas de tabaco transgénicas que tienen menos niveles de nicotina así como otras plantas o células huésped que contienen niveles modificados de una proteína de interés debido a la inclusión en la misma de un elemento senuelo de acción cis.
Patent UY-28166-A1 (UY)
Title: Aparato de identificacion
Inventor: FRANK FINLAYSON JOHN DOUGLAS
IPC: A01K11/00
Filed: 2004-01-19
Abstract: Aparato de identificación para identificar objetos, ganado u objetos en movimiento que tienen dispositivos electrónicos de identificación (EID), típicamente transpondedores, incluyendo el aparato de identificación múltiples dispositivos de lectura EID, típicamente antenas, posicionados en relación de separación, que definen múltiples pasillos, pudiendo pasar por cualquiera de ellos en una sola fila los objetos que llevan los EID que se deben leer y donde cada dispositivo de lectura EID está adaptado para leer cualquier EID cuando los objetos pasan individualmente por cualquiera de los pasillos y dispositivos de computación adaptados para registrar una sola vez daca EID portado por un objeto independientemente de la cantidad de dispositivos de lectura EID que lean el EID o independientemente de la dirección o de cuántas veces pasa el objeto por los múltiples pasillos. El aparato puede asociarse con un dispositivo de marcación adaptado para marcar los objetos o el ganado que no active los dispositivos de lectura EID.
Patent UY-29267-A1 (UY)
Title: Derivados de piperidina y su uso como agentes antiinflamatorios
Inventor: KOCHANNY MONICA J
IPC: C07D249/08
Filed: 2005-12-20
Abstract: Derivados de piperidina de las siguientes fórmulas y sus sales aceptables para uso farmacéutico, que son antagonistas funcionales de receptor de quimioquina CCCCR1 y por lo tanto son útiles como agentes antiinflamatorios, a composiciones farmacéuticas que contienen dichos derivados de piperidina o sus sales aceptables para uso famracéutico, y métodos de uso de los mismos.
Patent UY-31076-A1 (UY)
Title: Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lípido
Inventor: SCHOEPFER JOSEPH
IPC: A61P11/00
Filed: 2008-05-09
Abstract: La presente invención se refiere a compuestos de la fórmula I: a procesos para su preparación, más generalmente a estos compuestos para utilizarse en el tratamiento del cuerpo humano o animal, en el tratamiento de una enfermedad inflamatoria u obstructiva de las vías respiratorias, de trastornos que se presentan comúnmente en relación con transplantes, o de una enfermedad proliferativa, cuya enfermedad responda a la inhibición de las cinasas de la familia de cinasa de protína relacionada con la cinasa-P13.
Patent UY-31587-A1 (UY)
Title: Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica.
Inventor: JEAN-FRANCOIS PEYRONEL
IPC: A61K31/437
Filed: 2008-12-30
Abstract: DERIVADOS DE N-HETEROCICLICO-IMIDAZO[1,2-a] PIRIDINA-2-CARBOXAMIDAS de formula (I) en el estado de base o de sal de adicion a un ácido, en la que los sustituyentes y los índices son segun están especificados en la Memoria descriptiva y en las reivindicaciones. Se divulga los métodos de preparacion, la de los intermediarios y su aplicacion en el tratamiento o prevencion de enfermedades que implican los receptores nucleares Nurr-1 denominados NR4A2, NOT, TINUR, RNR-1 y HZF3.
Patent ES-179180-A1 (ES)
Title: PROCEDIMIENTOS INTRODUCIDOS EN LA CONSTRUCCIoN DE LOS GENERADORES ELÉCTRICOS DE AGUA CALIENTE
Filed: 1947-08-02
Abstract: Perfeccionamientos introducidos en la construcción de los generadores eléctricos de agua caliente, caracterizados porque los hilos de resistencia del cuerpo calentador (13) están dispuestos en un alojamiento (9) dentro de una válvula de la tubería de agua o dispositivo similar detrás del platillo de válvula (5), directamente en el camino del agua que pasa por la válvula.
Patent ES-180010-A1 (ES)
Title: UN MÉTODO DE MANUFACTURAR UN PRODUCTO RESINOSO QUE CONTIENE RESINAS DE oRGANO-POLISILOXANO
IPC: H01B3/46
Filed: 1947-10-06
Abstract: Método de manufacturar un producto resinoso que contiene resinas de órgano-polisiloxano caracterizado por mezclar de 99 8 50 partes en peso de un fenil alcohil polisiloxano con de 1 a 60 partes en peso de un terfenilo líquido que esta hidrogenado al menos en 40% y tratar al calor la mezcla para polimerizar más el fenil alcohil polixiloxano.